Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,372,880
+$353,125 QoQ
Shares Held
12,046
+6.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#299
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $606,603,850 across 15 Diagnostics & Research names. LH ranks #15 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
1,352,228 | $179,616,445 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
347,426 | $174,185,499 | |
| 3 | DHR |
Danaher Corp /De/
|
180,852 | $34,448,688 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
22,037 | $28,152,487 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
139,445 | $26,943,562 | |
| 6 | DGX |
Quest Diagnostics Inc
|
120,238 | $25,484,444 | |
| 7 | ILMN |
Illumina, Inc.
|
138,268 | $24,311,662 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
105,152 | $23,847,422 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,372,880 | 12,046 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,019,755 | 11,318 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,811,110 | 11,205 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $13,395,941 | 46,666 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $20,170,743 | 76,838 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $17,944,253 | 77,100 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,019,915 | 13,169 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,518,172 | 11,268 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,454,153 | 56,283 | Shares | Sole | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||